 |
USPTO FAILED TO CONSIDER ROUTINE SKILLS AND TECHNIQUES IN CONCEPTION ANALYSIS* *
Regents of U.C. v. Broad Inst., Inc., 22-1594, 22-1653
|
May 12, 2025 |
IPO Federal Circuit Summaries |
|
PRELIMINARY INJUNCTION WAS IMPROPER WHEN COMPETITIVE HEAD START WAS INEVITABLE* *
Incyte Corp. v. Sun Pharma. Indus., Ltd., 25-1162
|
May 07, 2025 |
IPO Federal Circuit Summaries |
|
PLANS TO DEVELOP DRUG WERE TOO SPECULATIVE TO CONFER STANDING*
Incyte Corp. v. Sun Pharma. Indus. Inc., 23-1300
|
May 07, 2025 |
IPO Federal Circuit Summaries |
|
USPTO MAY CONSIDER EVIDENCE AS OF THE TIME OF EXAMINATION IN DETERMINING REGISTRATION UNDER LANHAM ACT § 2(A)*
In re Foster, 23-1527
|
May 07, 2025 |
IPO Federal Circuit Summaries |
|
IPR ESTOPPEL DOES NOT APPLY TO EVIDENCE THE INVENTION WAS KNOWN OR USED BY OTHERS, ON SALE, OR IN PUBLIC USE* *
Ingenico Inc. v. IOENGINE LLC, 23-1367
|
May 07, 2025 |
IPO Federal Circuit Summaries |
|
FINTIV DIGITAL WALLET CLAIMED MEANS-PLUS-FUNCTION TERMS SUBJECT TO 35 U.S.C. § 112 ¶ 6 * *
Fintiv Inc. v. PayPal Holdings Inc., 23-2312
|
April 30, 2025 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT ADOPTS MILWAUKEE TEST FOR GENERICNESS * *
In re: PT Medisafe Techs., 23-1573
|
April 29, 2025 |
IPO Federal Circuit Summaries |
|
USPTO INCORRECTLY INTERPRETED “IN COMBINATION” RULE UNDER 35 U.S.C. § 311(B) * *
Qualcomm Inc. v. Apple Inc., 23-1208, 23-1209
|
April 23, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT DID NOT ERR IN DETERMINING THAT PHOSITA WOULD HAVE HAD KNOWLEDGE OF U.S. AND UK REGULATORY REQUIREMENTS * *
Sage Prods., LLC v. Stewart
|
April 15, 2025 |
IPO Federal Circuit Summaries |
|
PARALLEL LITIGATION COULD NOT BE CONSIDERED IN TRANSFER ANALYSIS *
In re SAP America, Inc., 25-118
|
April 10, 2025 |
IPO Federal Circuit Summaries |
|
USPTO MAY BE ABLE TO RECONSIDER TRADEMARK REGISTRABILITY AFTER FAILED OPPOSITION * *
Heritage Alliance, AFA Action Inc. v. Am. Policy Roundtable, 24-1155
|
April 09, 2025 |
IPO Federal Circuit Summaries |
|
APPLICATION’S PROSECUTION HISTORY DID NOT AFFECT CLAIMS OF RELATED PARALLEL APPLICATION * *
Azurity Pharms. Inc. v. Alkem Labs. Ltd., 23-1977
|
April 08, 2025 |
IPO Federal Circuit Summaries |
|
TRADE SECRET WAS PROPERLY ACCESSIBLE WHEN DEFENDANT COULD HAVE DISCOVERED IT * *
ams-OSRAM USA Inc. v. Renesas Elecs. Am. Inc., 22-2185, 22-2186
|
April 04, 2025 |
IPO Federal Circuit Summaries |
|
PROVISIONAL RIGHTS CANNOT BE GRANTED TO PATENTS ISSUED BEYOND EXPIRATION DATE*
In re Forest, 23-1178
|
April 03, 2025 |
IPO Federal Circuit Summaries |
|
APPELLANT’S REQUEST FOR REMITTITUR WAS NOT FORFEITED IN CONTEXT OF TRIAL *
Wash World Inc. v. Belanger Inc., 23-1841
|
March 24, 2025 |
IPO Federal Circuit Summaries |
|
*PROVISIONAL APPLICATION MUST SUPPORT SUBJECT MATTER CITED AS PRIOR ART TO CLAIM PROVISIONAL PRIORITY DATE *
In re Riggs, 22-1945
|
March 24, 2025 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT DECLINES TO EXPAND PROSECUTION DISCLAIMER ANALYSIS *
Maquet Cardiovascular LLC v. Abiomed Inc., 23-2045
|
March 21, 2025 |
IPO Federal Circuit Summaries |
|
DOCTRINE OF NATURAL EXPANSION CANNOT BE USED TO ESTABLISH TRADEMARK PRIORITY *
Dollar Fin. Grp., Inc. v. Brittex Fin. Inc., 23-1375
|
March 19, 2025 |
IPO Federal Circuit Summaries |
|
FAILURE TO TIMELY FILE UNDER 37 C.F.R. § 90.2(A)(3)(II) DID NOT AFFECT FEDERAL CIRCUIT’S JURISDICTION *
AMP Plus, Inc. v. DMF, Inc, 23-1997
|
March 19, 2025 |
IPO Federal Circuit Summaries |
|
SUA SPONTE SHOW CAUSE ORDER WAS WITHIN ITC’S DISCRETION *
Realtek Semiconductor Corp. v. Int’l Trade Comm., 23-1095
|
March 18, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT WAS NOT BOUND BY PREVIOUS CLAIM CONSTRUCTION IN APPLYING BECTON * *
Regeneron Pharms, Inc. v. Mylan Pharms Inc., 24-2351
|
March 14, 2025 |
IPO Federal Circuit Summaries |
|
REISSUED PATENTS ENTITLED TO PTE BASED ON ORIGINAL PATENT’S ISSUE DATE* *
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., 23-225
|
March 13, 2025 |
IPO Federal Circuit Summaries |
|
JEPSON CLAIM PREAMBLE REQUIRES A WRITTEN DESCRIPTION *
In re Xencor, Inc., 24-1870
|
March 13, 2025 |
IPO Federal Circuit Summaries |
|
MARKS MUST BE CONSIDERED GENERIC AT TIME OF REGISTRATION TO BE DENIED PROTECTION * *
Bullshine Distillery LLC v. Sazerac Brands, LLC, 23-1682, 23-1900
|
March 12, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT CONCLUSION FAILED TO FOLLOW FROM THE PREMISE DESCRIBING CLAIM LANGUAGE* *
Sierra Wireless, ULC v. Sisvel S.P.A., 23-1059, 23-1085, 23-1089, 23-1125
|
March 10, 2025 |
IPO Federal Circuit Summaries |
|
NO SPECIFIC THREAT OF INFRINGEMENT OR IDENTIFICATION OF INFRINGING PRODUCT NEEDED TO SHOW INJURY-IN-FACT*
CQV Co., Ltd. v. Merck Patent GMBH, 23-1027
|
March 10, 2025 |
IPO Federal Circuit Summaries |
|
ALIVECOR FORFEITED DISCOVERY ARGUMENT ON APPEAL*
Alivecor, Inc. v. Apple, Inc., 23-1512, 23-1513, 23-1514
|
March 07, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT CLAIM CONSTRUCTION IMPROPERLY IMPORTED LIMITATIONS INTO CLAIMS *
IQRIS Techs. LLC v. Point Blank Enters., Inc., 23-2062
|
March 07, 2025 |
IPO Federal Circuit Summaries |
|
SPECIFIC PROBLEMS UNKNOWN IN THE ART AT THE TIME OF THE INVENTION DID NOT NECESSARILY RENDER CLAIMED SOLUTION NON-OBVIOUS *
ImmunoGen, Inc. v. Stewart, 23-1762
|
March 06, 2025 |
IPO Federal Circuit Summaries |
|
USPTO PROPERLY DECLINED REQUEST FOR DIRECTOR REVIEW UNDER FRCP 60(B)(6) * *
Odyssey Logistics & Tech. Corp. v. Stewart, 23-2077
|
March 06, 2025 |
IPO Federal Circuit Summaries |
|
SECTION 337(A)(3)(B) DOMESTIC-INDUSTRY REQUIREMENT DOES NOT REQUIRE DOMESTIC MANUFACTURING ACTIVITY * * *
Lashify, Inc. v. Int’l Trade Comm., 23-1245
|
March 05, 2025 |
IPO Federal Circuit Summaries |
|
PRODUCT-BY-PROCESS CLAIMS ARE NOT AUTOMATICALLY INHERENTLY ANTICIPATED * *
Restem, LLC v. Jadi Cell, LLC, 23-2054
|
March 04, 2025 |
IPO Federal Circuit Summaries |
|
CLAIMS NOT DIRECTED TOWARD INELIGIBLE ABSTRACT IDEA DUE TO CONCRETE RELATIONSHIP BETWEEN RECITED PROPERTIES AND CLAIMED STRUCTURAL DETAILS* *
U.S. Synthetic Corp. v. Int’l Trade Comm., 23-1217
|
February 13, 2025 |
IPO Federal Circuit Summaries |
|
INFRINGEMENT CAUSE OF ACTION CANNOT BE PRECLUDED BY IPR DECISION FINDING IMMATERIALLY DIFFERENT CLAIMS UNPATENTABLE* *
Kroy IP Holdings LLC v. Groupon, Inc., 23-1359
|
February 10, 2025 |
IPO Federal Circuit Summaries |
|
PATENT INFRINGEMENT CASE REASSIGNED ON REMAND * *
Trudell Med. Int’l Inc. v. D R Burton Healthcare, LLC, 23-1777, 23-1779
|
February 07, 2025 |
IPO Federal Circuit Summaries |
|
SMALL MARKET SEGMENTS CAN BE SIGNIFICANT INVESTMENT UNDER DOMESTIC INDUSTRY REQUIREMENT * *
Wuhan Healthgen Biotech. Corp. v. Int’l Trade Comm., 23-1389
|
February 07, 2025 |
IPO Federal Circuit Summaries |
|
USPTO ERRONEOUSLY CONSTRUED ELEMENTS CLAIMED BY INTEGRATED CIRCUIT PATENT *
HD Silicon Solutions LLC v. Microchip Tech. Inc., 23-1397
|
February 06, 2025 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT DECLINES TO ADDRESS VALIDITY OF REVERSE DOCTRINE OF EQUIVALENTS*
Steuben Foods, Inc. v. Shibuya Hoppman Corp., 23-1790
|
January 24, 2025 |
IPO Federal Circuit Summaries |
|
PUBLISHED PATENT APPLICATION WAS A PRIOR ART PRINTED PUBLICATION AT THE TIME OF FILING * *
Lynk Labs, Inc. v. Samsung Electronics Co., 23-2346
|
January 14, 2025 |
IPO Federal Circuit Summaries |
|
STATE LAW CONVERSION CLAIM OVER METHOD OF BITCOIN MINING PREEMPTED BY FEDERAL PATENT LAW *
BearBox LLC v. Lancium LLC, 23-1922
|
January 13, 2025 |
IPO Federal Circuit Summaries |
